Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
63.40
+4.75 (8.10%)
At close: Aug 25, 2026, 4:00 PM EDT
64.51
+1.11 (1.75%)
After-hours: Aug 25, 2026, 7:52 PM EDT

Spruce Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
182931711926105
Market Cap Growth
3846.60%437.50%-85.46%361.35%-75.29%-81.46%
Enterprise Value
9484-3916-5819
Last Close Price
63.4087.1131.50219.7582.31334.50

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
--3.5311.82--
PB Ratio
2.082.190.601.560.380.94
P/TBV Ratio
2.182.190.601.560.380.94

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
---1.62--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.090.020.100.060.090.06
Net Debt / Equity Ratio
-1.06-1.13-1.25-1.20-1.06-0.74
Net Debt / EBITDA Ratio
2.271.690.641.771.541.96
Net Debt / FCF Ratio
2.071.450.642.761.752.29
Asset Turnover
--0.070.11--
Quick Ratio
8.785.112.543.946.3510.03
Current Ratio
9.235.172.904.186.7210.36
Return on Equity (ROE)
-105.98%-109.24%-100.70%-66.10%-51.35%-32.43%
Return on Assets (ROA)
-40.03%-36.41%-47.06%-34.28%-27.86%-18.17%
Return on Capital Employed (ROCE)
-43.50%-66.60%-187.40%-65.40%-64.60%-35.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-28.18%-41.79%-305.73%-40.17%-178.61%-40.41%
FCF Yield
-23.47%-35.74%-322.61%-27.90%-161.25%-34.37%
Buyback Yield / Dilution
-149.78%-39.34%-7.14%-63.68%-0.71%-289.93%